Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study

Breast-conserving therapy was once a contraindication in young breast cancer patients (aged ≤40 years). Emerging studies suggest that breast-conserving therapy and mastectomy could achieve similar prognosis in this population. However, the effect of molecular subtype disparity on surgical strategy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ping, Tang, Hailin, Zou, Yutian, Liu, Peng, Tian, Wenwen, Zhang, Kaiming, Xie, Xiaoming, Ye, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480363/
https://www.ncbi.nlm.nih.gov/pubmed/33356518
http://dx.doi.org/10.1177/1073274820976667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480363/
https://www.ncbi.nlm.nih.gov/pubmed/33356518
http://dx.doi.org/10.1177/1073274820976667

Ejemplares similares